Search for

Bibliographia Humboldtiana Index

Bibliographia Humboldtiana

III. Publications by Research Awardees in 2015

Medicine

Jeremic, Prof. Dr. Branislav

BioIRC - Bioengineering Research and Development Center, Serbia
Field of research: X-ray therapy, radiotherapy
Host: Prof. Dr. Michael Molls Technische Universität München
  • Branislav Jeremic.: Standard treatment option in Stage III nonsmall cell lung cancer. Case against trimodality therapy and consolidation drug therapy. In: Clin Lung Cancer. 16, 2015, p. 80 - 85 [Stage III, nonsmall cell lung cancer, trimodality therapy, maintenance chemotherapy].

  • Jane A. Shaw, Elvis M. Irusen, Frank von Groote-Bidlingmeier, James M. Warwick, Branislav Jeremic, Rebecca Du Toit, Coenrad FN Koegelenberg.: Integrated PET-CT for evaluation of mediastinal lymph node staging of non-small cell lung cancer in a Tuberculosis-endemic area: a five year prospective observational study. In: S Afr Med J. 105, 2015, p. 145 - 150 [positron emission tomography, lymph nodes, lung cancer, tuberculosis].

  • Branislav Jeremic, Elena Fidarova, Vinay Sharma, Mohammed Faheem, Aly A. Ameira, Chiraz N. Ben- Ammar, Ana Frobe, Fee N. Lau, Stephen Brincat, Glenn Jones.: The International Atomic Energy Agency (IAEA) Randomized Trial of Palliative Treatment of incurable Locally Advanced non small cell lung cancer (NSCLC) using Radiotherapy (RT) and Chemotherapy (CHT) in Limited Resource Setting. In: Radiother Oncol. 116, 2015, p. 21 - 26 [palliation, nonsmall cell lung cancer, radiotherapy, chemotherapy].

  • Peter, Hoskin, Ana Rojas, Elena Fidarova, Rakesh Jalali,Ana M. Merino, Adela Poitevin, Seam Oucrif, Sherif Abdel-wahab, Lotfi Kochbati, Aista Plieskiene, Francesc Casas, Suzana Stojanovic, Guenther Schneider, Branislav Jeremic. : IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases. In: Radiother Oncol. 116, 2015, p. 10 - 14 [bone metastasis, palliation, radiotherapy, a randomized trial].

  • Dorothy Lombe, Branislav Jeremic.: A Review of the Place and Role of Radiotherapy in Thymoma. In: Clin Lung Cancer. 16, 2015, p. 406 - 412 [radiotherapy, thymoma].

  • Branislav Jeremic.: State of the art in the treatment of lung cancer. In: S Afr Respir J,. 21, 2015, p. 59 - 65 [treatment, lung cancer].

  • Jose A. González-Ferreira, Juan J.Olasolo, Ignacio Azinovic, Branislav Jeremic .: Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature. In: Rep Pract Oncol Radiother . 20, 2015, p. 328 - 339 [overall treatment time, radiotherapy, head and neck cancer].

  • Wilson Roa, Lucyna Kepka, Narendra Kumar, Valery Sinaika, Juliana Matiello, Darejan Lomidze, Dalenda Hentati, Douglas G. de Castro D, Katarzyna Dyttus-Cebulok, Suzanne Drodge, Sunita Ghosh, Branislav Jeremic, Eduardo Rosenblatt, Elena Fidarova. : An IAEA Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients with Newly Diagnosed Glioblastoma Multiforme. In: J Clin Oncol. 33, 2015, p. 4145 - 4150 [elderly, frail patients, glioblastoma multiforme, radiotherapy, palliation, a randomized trial].

  • Virginie Rondeau, Jean-Pierre Pignon, Stefan Michiels; MACH-NC collaborative Group. (115 collaborators, including Jeremic B).: A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer. . 24:711-729, 2015. In: Stat Methods Med Res. 24, 2015, p. 711 - 729 [tumor progression, death, head and neck cancer, chemotherapy, meta analysis].

  • Branislav Jeremic. : Thoracic radiation therapy (TRT) in extensive disease small cell lung cancer (ED SCLC). In: Int J Radiat Oncol Biol Phys. 93, 2015, p. 7 - 9 [radiotherapy, extensive disease, small cell lung cancer].

  • Nikola Cihoric, Nenad Filipovic, Branislav Jeremic. : A call for careful interpretation of outcome of nonsurgical approach in clinical stage IIIA non-small cell lung cancer in the National Cancer Database!. In: Ann Thorac Surg. 99, 2015, p. 1111 - 1112 [outcomes, nonsurgical approaches, stage IIIA, nonsmall cell lung cancer].

  • Nikola Cihoric, Branislav Jeremic. : Elective Nodal Irradiation in Early Non-Small Cell Lung Cancer. In: Int J Radiat Oncol Biol Phys. 91, 2015, p. 1111 - 1112 [elective nodal irradiation, early stage, nonsmall cell lung cancer].

  • Branislav Jeremic, Francesc Casas, Pavol Dubinsky, Nikola Cihoric, Antonio Gomez-Caamano. : Trimodality treatment approach in stage III/pN2 nonsmall cell lung cancer. "Usually appropriate" may well be very inappropriate treatment option. In: Am J Clin Oncol. 38, 2015, p. 645 [trimodality treatment, stage IIIA, nonsmall cell lung cancer].

  • Branislav Jeremic, Nenad Filipovic, Biljana Milicic, Slobodan Milisavljevic. : Radiation therapy (RT) and chemotherapy (CHT) in Stage II nonsmall cell lung cancer (NSCLC) : Clinical entity neglected by radiation oncologists?. In: Lung Cancer. 90, 2015, p. 622 - 623 [stage II, nonsmall cell lung cancer, radiotherapy].

Lang, Prof. Dr. med. Karl Sebastian

Universität Duisburg-Essen, Germany
Field of research: Hepatology
Host: Prof. Dr. Jan Buer Universität Duisburg-Essen
  • Merches K, Khairnar V, Knuschke T, Shaabani N, Honke N, Duhan V, Recher M, Navarini AA, Hardt C, Häussinger D, Tümmler B, Gulbins E, Futerman AH, Hoffmann D, Lang F, Lang PA, Westendorf AM, Lang KS.: Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection. In: Cell Physiol Biochem. 36, 2015, p. 2379 - 92.

  • Shaabani N, Honke N, Dolff S, Görg B, Khairnar V, Merches K, Duhan 4, Metzger S, Recher M, Barthuber C, Hardt C, Proksch P, Häussinger D, Witzke O, Lang PA, Lang KS: IFN-γ licenses CD11b(+) cells to induce progression of systemic lupus erythematosus. In: J Autoimmun. 62, 2015, p. 11 - 21 [Autoantibodies; Fcgr2b; IFN-γ; Infection; Inflammation; Systemic lupus erythematosus; Virus].

  • Lang KS, Johnson TJ: Transcriptome modulations due to A/C2 plasmid acquisition. In: Plasmid. 80, 2015, p. 83 - 9 [A/C2; Crosstalk; Gene expression; HGT; RNA-Seq].

  • Khairnar V, Duhan V, Maney SK, Honke N, Shaabani N, Pandyra AA, Seifert M, Pozdeev V, Xu HC, Sharma P, Baldin F, Marquardsen F, Merches K, Lang E, Kirschning C, Westendorf AM, Häussinger D, Lang F, Dittmer U, Küppers R, Recher M, Hardt C, Scheffrahn I, Beauchemin N, Göthert JR, Singer BB, Lang PA, Lang KS: CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production. In: Nat Commun. 18, 2015.

  • Xu HC, Huang J, Khairnar V, Duhan V, Pandyra AA, Grusdat M, Shinde P, McIlwain DR, Maney SK, Gommerman J, Löhning M, Ohashi PS, Mak TW, Pieper K, Sic H, Speletas M, Eibel H, Ware CF, Tumanov AV, Kruglov AA, Nedospasov SA, Häussinger D, Recher M, Lang KS, Lang PA: Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection. In: J Virol. 89, 2015, p. 4748 - 59.

  • McIlwain DR, Grusdat M, Pozdeev VI, Xu HC, Shinde P, Reardon C, Hao Z, Beyer M, Bergthaler A, Häussinger D, Nolan GP, Lang KS, Lang PA: T-cell STAT3 is required for the maintenance of humoral immunity to LCMV. In: Eur J Immunol. 45, 2015, p. 418 - 27 [Chronic infection; Humoral immunity; LCMV; STAT3; T follicular helper cells].

  • Lang PA, Meryk A, Pandyra AA, Brenner D, Brüstle A, Xu HC, Merches K, Lang F, Khairnar V, Sharma P, Funkner P, Recher M, Shaabani N, Duncan GS, Duhan V, Homey B, Ohashi PS, Häussinger D, Knolle PA, Honke N, Mak TW, Lang KS: Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infection. In: Cell Death Differ. 22, 2015, p. 164 - 73.